Our Scientific Advisory Board

The members of the Issuer's scientific advisory board, none of whom are officers or employees, provide advice, assistance and consultation in the fields of drug development, clinical trials and fibrosis. The SAB consists of clinical advisors considered to be known opinion leaders in their respective fields, and they offer the Issuer advice and feedback regarding, the following:

the issuer's drug development programs
the opportunities provided by unmet needs and market opportunities and
the existence of new products and technologies among other things.

The following is a brief biography of each of the Issuer's Pulmonary Fibrosis and Bronchiolitis Obliterans clinical advisors, which includes a description of each individual's credentials and recent professional experience.


Daryl Knight Ph.D.
Dr. Daryl Knight is the Canada Research Chair in Airway Disease and Associate Director, James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research. He is an Associate Professor of Pharmacology and Therapeutics at the University of British Columbia, Vancouver.

Dr. Knight obtained his PhD at the University of Western Australia in 1993 and did post doctoral training at the University of British Columbia. From 1997 to 2001 he was a Senior Research Officer in the Asthma & Allergy Research Institute of the University of Western Australia and was Head of the Experimental Biology division of the Institute from 2002-2004. He was also an Adjunct Senior Lecturer in the Department of Medicine at the University of Western Australia.


Ganesh Raghu MD, FCCP, FACP
Dr. Ganesh Raghu is a world recognized opinion leader in Idiopathic Pulmonary Fibrosis (IPF). He is a professor of Pulmonary Medicine at the University Of Washington Medical Centre and a Director of the Lung transplant program there.

He has conducted several clinical trials for the Treatment of IPF with antifibrotic drugs. His current research interests include quality of life measures in IPF and Lung transplantation, as well as the treatment of rejection and infection in lung transplants.

Dr. Raghu received his M.D. in 1973 from Mysore Medical College, University of Mysore, Mysore, India. He Interned at University Hospitals, University of Mysore in1974 and was a Resident in General Medicine and Chest Medicine, Hartlepool General Hospital and Postgraduate Medical Center (University of Newcastle Upon Tyne), Hartlepool, England in 1977. In 1980 he conducted his Residency in Internal Medicine at State University of New York in Buffalo. He was the Chief Medical Resident at the State University of New York, Buffalo from1980-1981. Dr. Raghu moved to Seattle in 1983 to complete fellowships in Pulmonary and Critical Care Medicine as well as Lung Cell Biology at the University of Washington.


James R. Seibold M.D.
Dr. Seibold been on the faculty of UMDNJ from 1980-2004 where he had served as Chief of the Division of Rheumatology, Director of the Clinical Research Center and as the W.H. Conzen Chair of Clinical Pharmacology. Author of more than 300 scientific publications, he is considered a world thought leader in scleroderma, Raynaud's phenomenon and interventional research in the rheumatologic diseases. He has received multiple awards from arthritis and scleroderma patient organizations and appears on virtually every listing of "Best Doctors".


Dr. Andreas Zuckermann MD
Dr. Zuckermann is a world recognized leader in Heart and Lung transplantation. He is a Staff Surgeon in the Department of Cardiothoracic Surgery at University of Vienna in Austria and Co-Director of Cardiac Transplantation Program there. He is also a Director the International Society for Heart and Lung Transplantation.

He has been involved in over 170 thoracic transplantations and has conducted clinical research in post transplant patients. His current interests are focused on Heart lung transplantation and beating Heart transplants.

Dr. Zuckermann received his MD from Vienna Medical School, University of Vienna in 1991. From 1991 - 1993 he was the transplant co-ordinator in the Dept. of Cardiothoracic Surgery at the University Of Vienna. From 1993 to 2000 prior to his appointment as a Staff Surgeon he trained in Cardio-thoracic surgery at St. Polten Hospital in Vienna where he assisted in over 30 lung transplants.